NCT05735730Active, not recruiting
Can the Risk for AMD be Modulated?
Diet, Lifestyle, Systemic Medication and Genetics: Can the Risk for AMD be Modulated?
Source: ClinicalTrials.gov · Last updated 23 Sept 2025
Brief summary (registry, in English)
The goal of this Cross-sectional, interventional study is to learn about whether different risk factors, as Mediterranean diet, lifestyle and concomitant medication can modulate the risk imprinted by genetics in Age-related macular degeneration (AMD). The main question it aims to answer is: How the genetic risk interacts with environmental and lifestyle factors, especially Mediterranean diet and chronic medication, in order to assess how this interplay protects or presents higher risk for the establishment or the progression of AMD. Participants: Vital Signs will be measured; Medical History, Demographics, Nutritional/lifestyle habits and Family History of AMD will be recorded; Ophthalmological Examination will be performed Genetic analysis will be performed.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 1800 (actual)
- First submitted
- 22 Dec 2022
- Start date
- 26 Jun 2023
- Primary completion date
- 6 Feb 2025
- Lead sponsor
- Association for Innovation and Biomedical Research on Light and Image
- Diseases
- Macular degeneration
- NCT number
- NCT05735730
What you commit to
- Study type: Interventional
- Participants enrolled: 1800
- From 26 Jun 2023 to the primary completion date, 6 Feb 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- No exclusion criteria apply.
Who the study is looking for
- Adult subjects residing in the Lousã region who participated in the epidemiologic study;
- Subjects capable of understanding the information about the study and to give their written informed consent to enter the study;
- Subjects willing and able to comply with the study procedures.
Age in the registry: 55 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| AIBILI-CEC (AIBILI- Clinical Trials Centre) Coordinator of this site? Confirm its status | Coimbra | Portugal | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.